(P107) Vero SBRT Treatment of Moving Lung Tumors

Publication
Article
OncologyOncology Vol 29 No 4_Suppl_1
Volume 29
Issue 4_Suppl_1

Overall, 40%-thresholded 18F-FDG PET contours nonsignificantly enlarge PTVs when multiphase free-breathing, inspiration, and expiration breath-hold scans are used for Vero SBRT. Whether 18F-FDG PET contours improve local control of moving lung tumors treated by Vero SBRT needs further study.

Charles A. Kunos, MD, PhD, John P. Shanahan, MS; Summa Cancer Institute

PURPOSE: Intrafraction motion management of moving lung tumors during stereotactic ablative body radiotherapy (SBRT) remains challenging. We investigated whether 40%-thresholded 2-[18F] fluoro-2-deoxy-D-glucose (18F-FDG) positron emission tomography (PET) images enhanced intrafraction tracking capabilities of the Vero SBRT platform.

MATERIALS AND METHODS: Three patients with six total moving lung tumors had gross tumor volume (GTV) contours created on free-breathing, end-inspiration, and end-expiration breath-hold computed tomography (CT) images. A thresholded 40% maximum standard uptake value 18F-FDG PET contour was generated. The four individual contours contributed to a single image-guided internal target volume (ITV). Vero SBRT treatment planning was conducted on the free-breathing CT dataset, with the ITV expanded all around by 5 mm for a final planning target volume (PTV). The prescription for each lesion was 40 Gy in four fractions of 10 Gy given every other day. Non-coplanar radiation doses were determined using a Monte Carlo algorithm. T-test statistics were calculated to compare parameter means.

RESULTS: The PTV was 23 cm3 on average (standard deviation [SD] = 18 cm3) without the 18F-FDG PET contour and 36 cm3 on average (SD = 32 cm3) with the 18F-FDG PET contour (P = .41). The lung V20 Gy was 2.6% on average (SD = 0.9%) without the 18F-FDG PET contour and 2.8% on average (SD = 0.5%) with the 18F-FDG PET contour (P = .68). Vero SBRT gimbal pan-and-tilt range of 4 cm was not exceeded by the addition of the 18F-FDG PET contour to the ITV.

CONCLUSIONS: Overall, 40%-thresholded 18F-FDG PET contours nonsignificantly enlarge PTVs when multiphase free-breathing, inspiration, and expiration breath-hold scans are used for Vero SBRT. Whether 18F-FDG PET contours improve local control of moving lung tumors treated by Vero SBRT needs further study.

Proceedings of the 97th Annual Meeting of the American Radium Society - americanradiumsociety.org

Articles in this issue

(P005) Ultrasensitive PSA Identifies Patients With Organ-Confined Prostate Cancer Requiring Postop Radiotherapy
(P001) Disparities in the Local Management of Breast Cancer in the United States According to Health Insurance Status
(P002) Predictors of CNS Disease in Metastatic Melanoma: Desmoplastic Subtype Associated With Higher Risk
(P003) Identification of Somatic Mutations Using Fine Needle Aspiration: Correlation With Clinical Outcomes in Patients With Locally Advanced Pancreatic Cancer
(P004) A Retrospective Study to Assess Disparities in the Utilization of Intensity-Modulated Radiotherapy (IMRT) and Proton Therapy (PT) in the Treatment of Prostate Cancer (PCa)
(S001) Tumor Control and Toxicity Outcomes for Head and Neck Cancer Patients Re-Treated With Intensity-Modulated Radiation Therapy (IMRT)-A Fifteen-Year Experience
(S003) Weekly IGRT Volumetric Response Analysis as a Predictive Tool for Locoregional Control in Head and Neck Cancer Radiotherapy 
(S004) Combination of Radiotherapy and Cetuximab for Aggressive, High-Risk Cutaneous Squamous Cell Cancer of the Head and Neck: A Propensity Score Analysis
(S005) Radiotherapy for Carcinoma of the Hypopharynx Over Five Decades: Experience at a Single Institution
(S002) Prognostic Value of Intraradiation Treatment FDG-PET Parameters in Locally Advanced Oropharyngeal Cancer
(P006) The Role of Sequential Imaging in Cervical Cancer Management
(P008) Pretreatment FDG Uptake of Nontarget Lung Tissue Correlates With Symptomatic Pneumonitis Following Stereotactic Ablative Radiotherapy (SABR)
(P009) Monte Carlo Dosimetry Evaluation of Lung Stereotactic Body Radiosurgery
(P010) Stereotactic Body Radiotherapy for Treatment of Adrenal Gland Metastasis: Toxicity, Outcomes, and Patterns of Failure
(P011) Stereotactic Radiosurgery and BRAF Inhibitor Therapy for Melanoma Brain Metastases Is Associated With Increased Risk for Radiation Necrosis
Recent Videos
Harmonizing protocols across the health care system may bolster the feasibility of giving bispecifics to those with lymphoma in a community setting.
Although accuracy remains a focus in whole-body MRI testing in patients with Li-Fraumeni syndrome, comfortable testing experiences may ease anxiety.
Subsequent testing among patients in a prospective study may affirm the ability of cfDNA sequencing to detect cancers in those with Li-Fraumeni syndrome.
cfDNA sequencing may allow for more accessible, frequent, and sensitive testing compared with standard surveillance in Li-Fraumeni syndrome.
STX-478 showed efficacy in patients with advanced solid tumors regardless of whether they had kinase domain or helical PI3K mutations.
STX-478 may avoid adverse effects associated with prior PI3K inhibitors that lack selectivity for the mutated protein vs the wild-type protein.
Phase 1 data may show the possibility of rationally designing agents that can preferentially target PI3K mutations in solid tumors.
Funding a clinical trial to further assess liquid biopsy in patients with Li-Fraumeni syndrome may help with detecting cancers early across the board.
Michael J. Hall, MD, MS, FASCO, discusses the need to reduce barriers to care for those with Li-Fraumeni syndrome, including those who live in rural areas.
Related Content